Our results uncovered that down-regulated SAMD12 and CADM2 exacerbated the proliferation potency, demonstrating the tumor suppression potential of SAMD12 and CADM2 in liver tumors (Fig 9B–9D). The gene discussed is SAMD12; the disease is neoplasm.